Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up-Reference-Cited by-同舟云学术

Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up

Published:2016-10 Issue:8 Volume:26 Page:769-772
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Naguy Ahmed¹,Alamiri Bibi¹²,Al-Khadhari Souleiman¹³,Francis Konstantinos¹⁴

Affiliation:

1. Child and Adolescent Psychiatry, Kuwait Center for Mental Health, Alamanara Unit, Kuwait City, Kuwait.

2. Department of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts.

3. Department of Psychiatry, Kuwait University, Kuwait City, Kuwait.

4. Department of Child Psychiatry, Athens University, Chalandri, Greece.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2015.0083

Reference37 articles.

1. Obsessive-compulsive disorder

2. Clinical Characteristics of Response to Fluoxetine Treatment of Obsessive-Compulsive Disorder

3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.

4. Diagnostic and Statistical Manual of Mental Disorders

5. Obsessive-Compulsive Characteristics: From Symptoms to Syndrome

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lumateperone monotherapy for treatment-resistant obsessive-compulsive disorder in an adolescent;CNS Spectrums;2023-09-14

2. Pharmacotherapeutic Strategies and New Targets in OCD;The Neurobiology and Treatment of OCD: Accelerating Progress;2021

3. Lamotrigine Uses in Psychiatric Practice;American Journal of Therapeutics;2019-01

4. Treatment-resistant OCD – A psychopharmacological ‘touche d’art’;Asian Journal of Psychiatry;2018-04

5. Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder;Current Neuropharmacology;2017-08-28